Metrics as of 10/17/2026, 08:24 AM (Berlin time), refresh in progress.
AbbVie Stock
AbbVie Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Robert A. Michael
- Employees
- 57,000
- Market cap
- $70 B
- IPO
- 25/11/2022
AbbVie Inc. is a research-based biopharmaceutical company engaged in the development and sale of pharmaceutical products. Headquartered in North Chicago, USA, the company employs approximately 57,000 people. AbbVie focuses on treating various serious health conditions through its diverse therapeutic portfolio. The…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
AbbVie stock: price history
1D
+0.8%
1W
+2.9%
1M
+8.7%
6M
+35.5%
YTD
+22.3%
1Y
+23.1%
2Y
+43.3%
5Y
–
10Y
–
Ask the agents about AbbVie
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
4,221
Dividends
Comparable stocks
Frequently asked questions about AbbVie stock
What does AbbVie do?
AbbVie Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Robert A. Michael, the company employs around 57,000 people.
The IPO was on 25/11/2022; the stock trades on TSX under the ticker ABBV.TO.
Does AbbVie pay a dividend?
Yes. The last dividend was CA$0.24 per share, ex-date 15/10/2026, paid on 23/11/2026.
Which stocks are comparable to AbbVie?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get AbbVie stock analyzed?
Clicking "Analyze stock" lets five strategies assess AbbVie against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.